Literature DB >> 6655409

Effect of nigericin and varying potassium concentrations on the prolactin-stimulated synthesis of milk fat in explants of mammary alveolar tissue from rabbits.

J V Smith, I R Falconer.   

Abstract

The possible role of K+ as a 'second messenger' for prolactin was investigated. Explants obtained from mammary glands of pseudopregnant rabbits were cultured (a) in media with varying potassium concentrations and (b) in the presence of the potassium-specific ionophore, nigericin. The explants were examined histologically and the rate of protein synthesis was measured to determine the viability of the tissue. Increase in the rate of fatty acid synthesis in the presence of prolactin was used as a marker of prolactin stimulation. At low K+ concentrations prolactin-stimulated fatty acid synthesis decreased with the decrease in K+ concentration of the media, whereas there was no similar trend in the rate of protein synthesis. Nigericin (0.01-0.1 mumol/l) inhibited fatty acid synthesis and protein synthesis in the presence or absence of prolactin without significantly affecting tissue K+ content. The mechanism of nigericin inhibition is hence unclear and the results do not provide support for K+ as a 'second messenger' for prolactin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6655409     DOI: 10.1677/joe.0.0990261

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  2 in total

1.  The effect of progesterone on prolactin stimulation of fatty acid synthesis, glycerolipid synthesis and lipogenic-enzyme activities in mammary glands of pseudopregnant rabbits, after explant culture or intraductal injection.

Authors:  P Martyn; I R Falconer
Journal:  Biochem J       Date:  1985-10-15       Impact factor: 3.857

2.  Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome.

Authors:  Kristin A D Sauter; Lisa J Wood; John Wong; Mihail Iordanov; Bruce E Magun
Journal:  Cancer Biol Ther       Date:  2011-06-15       Impact factor: 4.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.